These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37182702)

  • 1. Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry.
    Muntyanu A; Milan R; Rahme E; Baron M; Netchiporouk E;
    J Am Acad Dermatol; 2024 Mar; 90(3):605-607. PubMed ID: 37182702
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of systemic sclerosis and exposure to solvents.
    Aryal BK; Khuder SA; Schaub EA
    Am J Ind Med; 2001 Sep; 40(3):271-4. PubMed ID: 11598973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma and occupational exposure.
    Bovenzi M; Barbone F; Betta A; Tommasini M; Versini W
    Scand J Work Environ Health; 1995 Aug; 21(4):289-92. PubMed ID: 8553004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group.
    Muntyanu A; Ouchene L; Zhou S; Hudson M; Rezaeian M; LaChance A; Litvinov IV; Baron M; Netchiporouk E;
    J Am Acad Dermatol; 2022 Nov; 87(5):1095-1097. PubMed ID: 35031410
    [No Abstract]   [Full Text] [Related]  

  • 5. [Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs].
    de la Espriella J; Crickx B
    Ann Dermatol Venereol; 1991; 118(12):948-53. PubMed ID: 1724723
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffused systemic sclerosis due to occupational solvent exposure.
    Alishiri GH; Saburi A; Bayat N; Saburi E
    Rheumatol Int; 2013 Jun; 33(6):1649-50. PubMed ID: 22238027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Occupational exposure and systemic sclerosis. Literature review and result of a self-reported questionnaire].
    Granel B; Zemour F; Lehucher-Michel MP; Moulin P; Disdier P; Durand JM; Gaudart J; Serratrice J; Rossi P; Weiller PJ; Frances Y
    Rev Med Interne; 2008 Nov; 29(11):891-900. PubMed ID: 18602199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors.
    Calvani N; Silvestris F; Dammacco F
    Ann Ital Med Int; 2001; 16(3):175-8. PubMed ID: 11692907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma and solvent exposure among women.
    Garabrant DH; Lacey JV; Laing TJ; Gillespie BW; Mayes MD; Cooper BC; Schottenfeld D
    Am J Epidemiol; 2003 Mar; 157(6):493-500. PubMed ID: 12631538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Scleroderma and occupational factors: a case-control study and analysis of literature].
    Betta A; Tommasini M; Bovenzi M; Barbone F; Versini W; Romeo L
    Med Lav; 1994; 85(6):496-506. PubMed ID: 7731408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is occupational organic solvent exposure a risk factor for scleroderma?
    Nietert PJ; Sutherland SE; Silver RM; Pandey JP; Knapp RG; Hoel DG; Dosemeci M
    Arthritis Rheum; 1998 Jun; 41(6):1111-8. PubMed ID: 9627022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A follow-up study of occupational styrene exposure and risk of autoimmune rheumatic diseases.
    Hjuler Boudigaard S; Stokholm ZA; Vestergaard JM; Mohr MS; Søndergaard K; Torén K; Schlünssen V; Kolstad HA
    Occup Environ Med; 2020 Feb; 77(2):64-69. PubMed ID: 31848232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can scleroderma be induced by anesthetics? Case report.
    Magnavita N
    Med Pr; 2016; 67(4):557-60. PubMed ID: 27623836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to chemicals and systemic sclerosis.
    Czirják L; Csiki Z; Nagy Z; Tóth E
    Ann Rheum Dis; 1995 Jun; 54(6):529. PubMed ID: 7632101
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products.
    Maître A; Hours M; Bonneterre V; Arnaud J; Arslan MT; Carpentier P; Bergeret A; de Gaudemaris R
    J Rheumatol; 2004 Dec; 31(12):2395-401. PubMed ID: 15570640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents.
    Povey A; Guppy MJ; Wood M; Knight C; Black CM; Silman AJ
    Arthritis Rheum; 2001 Mar; 44(3):662-5. PubMed ID: 11263781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized Scleroderma, Systemic Sclerosis and Cardiovascular Risk: A Danish Nationwide Cohort Study.
    Hesselvig JH; Kofoed K; Wu JJ; Dreyer L; Gislason G; Ahlehoff O
    Acta Derm Venereol; 2018 Mar; 98(3):361-365. PubMed ID: 29136260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of occupational exposure with features of systemic sclerosis.
    Marie I; Menard JF; Duval-Modeste AB; Joly P; Dominique S; Bravard P; Noël D; Gehanno JF; Bubenheim M; Benichou J; Levesque H
    J Am Acad Dermatol; 2015 Mar; 72(3):456-64. PubMed ID: 25582539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to solvents in female patients with scleroderma.
    Czirják L; Kumánovics G
    Clin Rheumatol; 2002 May; 21(2):114-8. PubMed ID: 12086160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.